In the news | 4th June 2013

R&D: Are true drug breakthroughs a thing of the past?

Fierce Biotech

June 2013

One of the most intense discussions at ASCO over the past few days has zeroed in on the FDA’s new “breakthrough” drug status. The agency is offering developers essentially an open door at the FDA to any program that qualifies, urging on R&D teams with quick responses and help adapting trials and hurrying the review process with the aim of getting more “transformative” drugs to the market faster.

Read the article here »

About IDBSContact us

More news

IDBS Joins BioPhorum

IDBS, a leading R&D technology and solutions provider and Tableau, the world’s leading analytics platform, announced a strategic partnership to integrate Tableau into the IDBS suite of products. The collaboration will be based on embedding Tableau’s visual and analytics capabilities into the IDBS product offerings.

Read more

i3 2021 On Demand

i3 our premier annual customer event where we bring together science, IT and R&D business leaders to share ideas, create new insights and advance innovation and this year we went virtual. During i3 you will gain insights from your peers…

Read more